Skip to main content

Table 3 NHB treatment pattern during 30 days after birth

From: Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States

Treatment pattern

Treated hemolytic NHB cohort

(N = 1373)

During birth hospitalization (mutually exclusive)

 Any NHB treatment during birth hospitalization, n%

949 (69.1)

 Phototherapy only, n%

937 (68.2)

 IVIg only, n%

0 (0)

 Exchange transfusion only, n%

4 (0.3)

 Phototherapy + IVIg, n%

2 (0.1)

 Phototherapy + Exchange transfusion, n%

6 (0.4)

 IVIg + Exchange transfusion, n%

0 (0)

 Phototherapy + IVIg + Exchange transfusion, n%

0 (0)

During 30 days after birth (mutually exclusive)

 Phototherapy only, n%

1358 (98.9)

 IVIg only, n%

0 (0)

 Exchange transfusion only, n%

4 (0.3)

 Phototherapy + IVIg, n%

2 (0.1)

 Phototherapy + Exchange transfusion, n%

9 (0.7)

 IVIg + Exchange transfusion, n%

0 (0)

 Phototherapy + IVIg + Exchange transfusion, n%

0 (0)

  1. NHB neonatal hyperbilirubinemia, IVIg intravenous immunoglobulin